Physician profile
Mark Palmer
NPI 1376804260
$5,836.54
in general payments reported to CMS, 2019-2025
8 companies · $1,656 in 2025
The $1,656 reported for 2025 was more than what 98% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $526 · 2022: $1,195 · 2023: $1,070 · 2024: $1,389 · 2025: $1,656.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,125 · Education: $815 · Food and Beverage: $711 · Consulting Fee: $400 · Entertainment: $64.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,124.82 |
| Education | $814.53 |
| Food and Beverage | $711.16 |
| Consulting Fee | $400.00 |
| Entertainment | $64.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $2,056.01 | 2024-2025 | 3m Filtek, Filtek, Clarity Aligners |
| 3m Company | $1,894.07 | 2020-2023 | 3m Espe Filtek Supreme Ultra Universal Restorative, Relyx Unicem 2 Automix, Filtek |
| Dentsply Sirona INC | $807.85 | 2020-2024 | Suresmile |
| Patterson Companies, INC. | $750.00 | 2024 | |
| Ultradent Products INC | $168.53 | 2022 | |
| Kuraray America INC. | $102.53 | 2022 | |
| Zimvie INC. | $41.43 | 2023 | |
| Nobel Biocare USA | $16.12 | 2023 | Nobelactive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Palmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.